Rorsman
Grant Funded
|
Project Code |
Task |
Grant Name |
Sponsor |
End date |
|
AVR02390 |
H700.01 |
Impaired Pancreatic Beta Cell |
Medical Research Council |
31-Oct-22 |
|
CCRZJC00 |
H711.01 |
Novo Fellowship - Thomas Hill |
Novo Nordisk |
04-Nov-21 |
|
H7D00020 |
H700.01 |
support for Investigation of intra-islet |
John Fell |
28-Feb-22 |
|
H7R00180 |
H700.01 |
KATP channel-dependent and independent regulation of the glucagon-secreting pancreatic a-cell |
Diabetes UK |
28-Feb-22 |
|
H7R00340 |
H700.01 |
Regulation of glucagon secretion |
Wellcome Trust |
30-Jul-21 |
|
H7R00420 |
H700.01 |
Investigating Glucagon Secretion in HNF1 Alpha |
OHSRC |
01-Aug-22 |
|
H7R00520 |
H700.01 |
DEPTH |
Leona M and Harry B Helmsley Charitable Trust |
31-May-21 |
|
H7R00540 |
H700.01 |
Intra Islet Glucagon Secretion |
The Royal Society |
30-Mar-22 |
|
H7R00550 |
H700.01 |
ER CA2+ |
EFSD |
31-Mar-21 |
|
H7R00650 |
H700.01 |
Single Alpha Cell |
JDRF (USA) |
30-Sep-21 |
|
H7R00660 |
H700.01 |
Pharma Modulation |
Helmsley Trust |
31-Jul-23 |
|
H7R00680 |
H700.01 |
Insulin Vesicle Dynamics |
Diabetes UK |
31-Aug-24 |
|
H7R00780 |
H700.01 |
Somatostatin Secreting Delta Cell |
Alan and Babette Sainsbury |
28-Dec-21 |
|
H7R00850 |
H700.01 |
The role of impaired glucagon secretion in life-threatening hypoglycaemia of type 1 diabetes: mechanism and therapeutic potential |
Medical Research Council |
03-Jan-25 |
General Ledger Codes
|
Cost Centre |
Description |
|
H77500 |
Rorsman PI Account |